NEW YORK, June 19, 2017 /PRNewswire/ -- CEFALY Technology announced today that Cefaly®, the first FDA-approved external trigeminal nerve stimulation device for the prevention of frequent episodic migraine attacks, will become available for purchase via PayPal Credit starting this June, in a nod toward Migraine Awareness Month. This means migraineurs who are approved by the online payments system, can get relief now and pay later, interest-free, for up to 6-months; making the $349 one-time cost for medical device less than $59 per month – when paid over a half-year period.
"We're excited to offer migraineurs a way to more quickly find relief," said Dr. Pierre Rigaux, the chief executive officer of CEFALY Technology, and a member of the team that invented the device. "By using PayPal Credit, we've found a way to make the Cefaly device more immediately accessible to people with migraines while we continue to work toward having the Cefaly device approved by insurance companies."
Cefaly® is an electronic, battery-powered, prescription-only device that is placed on the forehead for 20-minutes once a day, using a self-adhesive electrode and a magnetic connection. The device sends tiny electrical impulses through the skin to desensitize the upper branches of the trigeminal nerve and reduce the frequency of migraine attacks. In clinical trials, compliant Cefaly® users experienced an 81% satisfaction rate, a 75% reduction in intake of migraine medication, and a 54% reduction in migraine attacks.
Cefaly® costs $349 and comes with a 60-day money back guarantee. A pack of three electrodes costs $25 and each electrode may be re-used up to 20 times. Cefaly® is available by prescription-only and indicated for patients 18 years of age and older. Women who are pregnant or could become pregnant should check with their doctor before using Cefaly®. Only 4.3% of people in clinical trials reported side effects -- all of which were minor and fully reversible.
About CEFALY Technology
CEFALY Technology is a Belgium-based company, with US offices based in Wilton, Connecticut, specializing in electronics for medical applications. It has developed external cranial stimulation technology for applications in the field of neurology; in particular for treating migraines. For more information, visit http://www.cefaly.us. Find Cefaly on Twitter: @Cefaly, Facebook: http://www.facebook.com/CefalyEN, and YouTube: http://www.youtube.com/c/CEFALYTechnology.
Media Contact: Maria Coder
SOURCE CEFALY Technology